Viewing Study NCT03537157


Ignite Creation Date: 2025-12-24 @ 6:48 PM
Ignite Modification Date: 2026-01-07 @ 11:43 AM
Study NCT ID: NCT03537157
Status: TERMINATED
Last Update Posted: 2021-09-27
First Post: 2018-05-15
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Multicentre Study on Rifaximin in Post-operative Endoscopic Crohn's Disease Recurrence Prevention
Sponsor: Alfasigma S.p.A.
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module